A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy.
METHODS
The quality of life in patients who elected to receive hormonal therapy for newly diagnosed asymptomatic metastatic prostate cancer was compared with a comparable group of patients who chose to defer immediate intervention.


CONCLUSIONS
The premise that active therapy, despite its side effects, would improve or maintain the psychosocial quality of life was not substantiated, and the no-therapy group had better physical and sexual functioning.
Herr
H W
HW
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
Kornblith
A B
AB
Ofman
U
U
D000368:Aged; D004054:Diethylstilbestrol / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D017060:Patient Satisfaction; D011471:Prostatic Neoplasms / Q000523:psychology / Q000628:therapy; D011788:Quality of Life; D012725:Sexual Behavior / Q000187:drug effects; D011795:Surveys and Questionnaires
D007987:Gonadotropin-Releasing Hormone; D004054:Diethylstilbestrol